A Phase II Study of the Effect of ACE Inhibitors on Pro-Angiogenic Hormones in Cancer Patients With Hypertension.
Phase of Trial: Phase II
Latest Information Update: 12 Jul 2018
At a glance
- Drugs Benazepril (Primary) ; Lisinopril (Primary) ; Losartan (Primary) ; Ramipril (Primary)
- Indications Hypertension
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 31 Jan 2013 Planned End Date changed from 1 Feb 2014 to 1 Feb 2016 as reported by ClinicalTrials.gov.
- 17 Apr 2012 Planned End Date changed from 1 Feb 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.